Found: 25
Select item for more details and to access through your institution.
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 457, doi. 10.1007/s10120-020-01124-x
- By:
- Publication type:
- Article
MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 341, doi. 10.1007/s10120-020-01123-y
- By:
- Publication type:
- Article
Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 515, doi. 10.1007/s10120-020-01121-0
- By:
- Publication type:
- Article
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 503, doi. 10.1007/s10120-020-01119-8
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Gastric equivalent of the 'Holy Plane' to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson's historic schema.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 273, doi. 10.1007/s10120-020-01142-9
- By:
- Publication type:
- Article
SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 402, doi. 10.1007/s10120-020-01138-5
- By:
- Publication type:
- Article
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 492, doi. 10.1007/s10120-020-01136-7
- By:
- Publication type:
- Article
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 392, doi. 10.1007/s10120-020-01135-8
- By:
- Publication type:
- Article
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 479, doi. 10.1007/s10120-020-01134-9
- By:
- Publication type:
- Article
Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 368, doi. 10.1007/s10120-020-01133-w
- By:
- Publication type:
- Article
The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 292, doi. 10.1007/s10120-020-01132-x
- By:
- Publication type:
- Article
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 382, doi. 10.1007/s10120-020-01130-z
- By:
- Publication type:
- Article
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 535, doi. 10.1007/s10120-020-01129-6
- By:
- Publication type:
- Article
Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 314, doi. 10.1007/s10120-020-01128-7
- By:
- Publication type:
- Article
Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 526, doi. 10.1007/s10120-020-01127-8
- By:
- Publication type:
- Article
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 352, doi. 10.1007/s10120-020-01126-9
- By:
- Publication type:
- Article
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 417, doi. 10.1007/s10120-020-01125-w
- By:
- Publication type:
- Article
Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 283, doi. 10.1007/s10120-020-01113-0
- By:
- Publication type:
- Article
Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 327, doi. 10.1007/s10120-020-01120-1
- By:
- Publication type:
- Article
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 445, doi. 10.1007/s10120-020-01116-x
- By:
- Publication type:
- Article
Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 302, doi. 10.1007/s10120-020-01117-w
- By:
- Publication type:
- Article
Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 435, doi. 10.1007/s10120-020-01115-y
- By:
- Publication type:
- Article
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3).
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 428, doi. 10.1007/s10120-020-01112-1
- By:
- Publication type:
- Article